Diabetes Drug Actos May Raise Risk for Bladder Cancer: FDA
The other drug in this class, Avandia, is already off U.S. market due to heart risksContinue Reading
The other drug in this class, Avandia, is already off U.S. market due to heart risksContinue Reading
Avoid blistering sunburnsContinue Reading
Total expenses, including prescriptions, average more than $9,000 a year, U.S. study findsContinue Reading
Inadequate cleansing results in high miss rate, researchers sayContinue Reading
Some Mississippi women can expect to die younger than women in El Salvador, new analysis claimsContinue Reading
Genetic screen helps doctors find HER2-positive patients who will respond to HerceptinContinue Reading
Screens cells for copies of HER2 geneContinue Reading
Label changes include curbs on certain products claiming to be ‘sunblocks’ and cancer-preventingContinue Reading
Report adds styrene, formaldehyde to the list of monitored chemicalsContinue Reading
Study found small increase in incidence, but experts suggest using ear piece, speaker phone to be safeContinue Reading
A push to recognize and treat heart attacks in women has unintended consequence, expert saysContinue Reading
Calling for warning labels, FDA says meds shouldn’t be given until other urological conditions are ruled outContinue Reading
One in 8 patients received treatment unsupported by medical data or guidelines, study findsContinue Reading
Younger patients, those with lung, thyroid cancer, leukemia/lymphoma affected most, study showsContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.